StockIQpro
NYSE:YCBD

cbdMD, Inc.

cbdMD, Inc.'s revenue fell 1.5% in fiscal 2025 to $19.2M while operating margin rose to −11.3%, its highest in 10 years. Free cash flow was −$1.6M, −8.5% of revenue, and the diluted share count rose 646.2%.Summary generated from cbdMD, Inc.'s SEC filings. Latest annual report filed Dec 19, 2025.

Revenue (FY25)$19.2M
Revenue growth−1.5%
Revenue, 5-yr CAGR−14.5%
Gross margin62.4%
Operating margin−11.3%
Net margin−10.6%
ROICn/a
Return on equity−44.4%
Debt / equityn/a
Free cash flow−$1.6M
FCF margin−8.5%
Share count change+646.2%

Financials

Fiscal years, $M
Item20212022202320242025
Revenue4435241919
Operating income−20−78−22−3−2
Net income−23−70−23−4−2
Free cash flow−14−16−5−1−2

Recent filings

From SEC EDGAR

Peers

Perfumes, cosmetics & other toilet preparations